China Meheco Group Co

China Meheco Group Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of China Meheco Group Co (600056.SS) as of Oct 23, 2026 is 15.06. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 26.57 — a change of -43.33% (lower).

EV/FCF

15.06

YoY

-43.33%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of China Meheco Group Co is 2025 15.06 . EV/FCF (Enterprise Value to Free Cash Flow) of China Meheco Group Co was 2024 26.57 . It decreases by -43.33% lower compared to the previous year.

The China Meheco Group Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-51.29 CNY
Jan 1, 2019
-50.67 CNY
Jan 1, 2020
13.45 CNY
Jan 1, 2021
-128.33 CNY
Jan 1, 2022
11.93 CNY
Jan 1, 2023
34.10 CNY
Jan 1, 2024
26.57 CNY
Jan 1, 2025
15.06 CNY
The China Meheco Group Co EV/FCF history
YEAREV/FCFYoY
15.06-43.33%
26.57-22.10%
34.10+185.90%
11.93-109.29%
-128.33-1,054.26%
13.45-126.54%
-50.67-1.20%
-51.29-256.63%
32.74+108.38%
15.71+2.71%
15.30-5.54%
16.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

China Meheco Group Co Stock analysis

What does China Meheco Group Co do? China Meheco Group Co., Ltd. generates revenue through its Industrial Pharmaceutical segment, which manufactures and distributes chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces. The Commercial Pharmaceutical segment focuses on wholesale and distribution of pharmaceuticals and medical devices. The Trading segment handles international exporting and medical resourcing introduction. The company serves healthcare providers, hospitals, and pharmacies through its wholesale operations, targeting the pharmaceutical and medical device markets in China and internationally. The Industrial Pharmaceutical segment produces chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces for distribution. The Commercial Pharmaceutical segment supplies pharmaceuticals and medical devices to healthcare institutions and retailers. The Trading segment facilitates international exports of pharmaceutical products and introduces medical resources globally, catering to global healthcare markets. China Meheco's revenue streams are derived from the sale of pharmaceutical products across its three segments. The Industrial segment manufactures and sells chemical and traditional Chinese medicine products, while the Commercial segment distributes these products through wholesale channels. The Trading segment earns from exporting pharmaceuticals and managing international medical resource procurement for global clients. China Meheco Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about China Meheco Group Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of China Meheco Group Co is 15.06 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of China Meheco Group Co changed from 26.57 to 15.06, representing a -43.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) China Meheco Group Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s China Meheco Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — China Meheco Group Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — China Meheco Group Co